Gian Maria Giamporcaro

Gian Maria Giamporcaro

Auto-generated profile, based on publicly available information

Gian Maria Giamporcaro

San Raffaele Scientific Institute, Diabetes Research Institute, Milan, Italy

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2013 in Diabetes
Verified
Journal Article
Open access
PDF file
AVAndrea Valle
Andrea Valle
GGGian Maria Giamporcaro
Gian Maria Giamporcaro
MSMarina Scavini
Marina Scavini
ASAngela Stabilini
Angela Stabilini
PGPauline Grogan
Pauline Grogan
MBManuela Battaglia
Manuela Battaglia
Human type 1 diabetes (T1D) is an autoimmune disease associated with major histocompatibility complex polymorphisms, β-cell autoantibodies, and autoreactive T cells. However, there is increasing evidence that innate cells may also play critical roles in T1D. We aimed to monitor peripheral immune cells in early stages of T1D (i.e., in healthy autoantibody-positive subjects) and in more advanced phases of the disease (i.e., at disease onset and years after diagnosis). We found a mild but significant and reproducible peripheral neutropenia that both precedes and accompanies the onset of T1D. This reduction was not due to peripheral neutrophil cell death, impaired differentiation, or the presence of anti-neutrophil antibodies. Neutrophils were observed by electron microscopy and immunohistochemical analysis in the exocrine pancreas of multiorgan donors with T1D (both at onset and at later stages of the disease) and not in that of multiorgan donors with type 2 diabetes or nondiabetic donors. These pancreas-infiltrating neutrophils mainly localized at the level of very small blood vessels. Our findings suggest the existence of a hitherto unrecognized clinical phenotype that might reflect unexplored pathogenic pathways underlying T1D.